查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1429013

流式细胞仪市场：按产品与服务、按技术、按应用、按最终用户、按地区、机会、预测，2017-2031 年

Flow Cytometry Market Assessment, By Products and Service, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 223 Pages | 商品交期: 3-5个工作天内

价格

全球流式细胞仪市场规模预计将从 2023 年的 50.1 亿美元成长到 2031 年的 92 亿美元，在 2024-2031 年预测期内复合年增长率为 7.89%。老年人口的增加、慢性病和传染患者病率的上升正在推动全球流式细胞仪市场的成长。流式细胞仪是一种强大的工具，可应用于免疫学、病毒学、分子生物学、癌症生物学和传染病监测等多个领域。此外，用于开发最新技术和产品的医疗保健研发支出的增加预计将进一步推动市场。

流式细胞仪的技术进步和新产品的推出正在对该行业产生重大影响。一项值得注意的发展是多家公司将光谱流式细胞仪技术商业化。这些进展对于解决癌症、免疫缺陷疾病和传染病等疾病日益普及的问题至关重要。预计它将在个人化医疗、药物发现和开发中发挥重要作用。然而，先进流式细胞仪设备的高成本仍然是一个挑战，并可能限制其对小型研究机构和新兴国家的可用性。此外，政府正在努力改善发展中国家和不发达国家对这些技术的获取，多家大公司的存在，以及利用公共和私营公司来设计先进的流式细胞术设备和设备。上市公司之间的持续联盟正在推动市场发展生长。

由于世界各地慢性病和传染病的增加，对流式细胞仪的需求正在迅速增加。流式细胞仪在癌症、HIV、爱滋病、结核病和许多其他疾病的检测和分析中发挥重要作用。医疗专业人员对流式细胞仪准确性和灵敏度的认识不断提高，有助于该行业的发展。

根据世界卫生组织2023年的统计数据，全球每年有4,100万人因慢性病死亡。它影响所有年龄层的人，无论地区或国家。久坐的生活方式、不健康的饮食以及过度吸烟和饮酒是慢性病盛行率增加的主要危险因子。对疾病及其病原体的早期诊断、准确检测和早期干预是对抗日益流行的慢性病的唯一解决方案。这使得医疗保健专业人员能够使用流式细胞仪和高效测试选项等先进技术，这是主要的成长动力。

本报告调查了全球流式细胞仪市场，并提供了市场概述，以及按产品/服务、技术、应用、最终用户、地区和进入市场的公司概况划分的趋势。

目录

第一章研究方法论

第二章 专案范围与定义

第三章执行摘要

第 4 章 2017-2031 年全球流式细胞仪市场前景

  • 市场规模及预测
  • 按产品/服务
  • 按技术
  • 按用途
  • 按最终用户
  • 按地区
  • 按公司划分的市占率 (%)，2023 年

第 5 章 2017-2031 年全球流式细胞仪市场展望（按地区）

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第 6 章 市场测绘，2023 年

第七章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

第九章 监理架构与创新

第十章 主要与企业状况

第11章价格分析

第十二章案例研究

第十三章 主要公司展望

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Sysmex Asia Pacific Pte Ltd.
  • Agilent Technologies, Inc.
  • Sony Biotechnology Inc. LLC
  • Enzo Life Sciences, Inc.
  • Cytek Biosciences, Inc.
  • Sartorius AG
  • Apogee Flow Systems Ltd.
  • Luminex Corporation

第十四章 战略建议

第十五章 查询及免责声明

Product Code: MX11009

Global flow cytometry market is projected to witness a CAGR of 7.89% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 9.2 billion in 2031. The increasing geriatric population and the rising prevalence of chronic and infectious diseases drive growth in the global flow cytometry market. Flow cytometry is a powerful tool with applications in multiple disciplines such as immunology, virology, molecular biology, cancer biology, and infectious disease monitoring. Moreover, increasing healthcare expenditure on research and development for the development of the latest technologies and products is further expected to drive the market.

Technological advancements and new product launches in flow cytometry have significantly impacted the industry. One notable development is various companies' commercial launch of spectral flow cytometry technology. These advancements are crucial in addressing the increasing prevalence of diseases, such as cancer, immunodeficiency disorders, and infectious diseases. They are expected to play a vital role in personalized medicine, drug discovery, and development. However, the high cost of advanced flow cytometry equipment remains challenging, potentially limiting accessibility for smaller research facilities or emerging countries. Moreover, government initiatives for improving access to these technologies in developing and under-developed countries, the presence of several leading players, and ongoing partnerships between public and private companies for engineering advanced flow cytometry devices and instruments are facilitating market growth.

Increasing Prevalence of Chronic and Infectious Diseases

There has been a surge in the demand for flow cytometry due to the rising number of chronic and infectious diseases worldwide. Flow cytometry plays a crucial role in detecting and analyzing diseases such as cancer, HIV, AIDS, TB, and many more. Rising awareness among healthcare professionals regarding the accuracy and sensitivity of flow cytometry is contributing to industry growth.

According to WHO 2023 statistics, chronic diseases are responsible for 41 million deaths every year at a global level. This affects people of all age groups, irrespective of their region or country. A sedentary lifestyle, unhealthy diet, and excessive tobacco and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases. Early diagnosis, accurate detection, and early intervention of the disease and its disease-causing agents are the only solutions to combat the growing prevalence of chronic diseases. This, in turn, enables healthcare professionals to use advanced technologies and highly efficient testing options, such as flow cytometry, acting as a major growth-inducing factor.

Technological Advancements

With a high prevalence of cancer, AIDS, and many other infectious diseases, there is an increasing demand to bring innovation in the flow cytometry industry that can enhance the accuracy of diagnosis and gather insights related to cell structure and functions. Key players are constantly investing in research and development to launch innovative products and instruments to facilitate flow cytometry technological advancements. In June 2023, Becton, Dickinson and Company, a global leader in medical technology, announced that it has launched an innovative automated instrument "BD FACSDuet", that can prepare samples for clinical diagnostics using flow cytometry to improve standardization and reproducibility in cellular diagnostics. The entire sample preparation process, including cocktailing, washing, and centrifuging, is automated by this product. These samples are then transferred to the physically integrated BD FACSLyric clinical flow cytometry system without any human intervention.

Government Initiatives

Government initiatives are playing a significant role in supporting the field of flow cytometry. One notable example is the establishment of the NIST Flow Cytometry Standards Consortium, which brings together industry, academia, and government to identify and address measurement and standard needs across the flow cytometry field. Additionally, government support through funds, grants, and public-private partnerships is contributing to the growth of the flow cytometry market, particularly in the context of research activities such as cancer, stem cell, and HIV studies. These initiatives are crucial in advancing the field of flow cytometry and addressing standardization issues, ultimately contributing to the development of new and innovative technologies in the market.

In August 2022, NanoCellect Biomedical Inc., a leader in developing and manufacturing microfluidic cells, announced that it received a grant of USD 1.8 million from Small Business Innovation Research (SBIR). This fund was granted to assist NanoCellect Biomedical Inc. in developing AI-based imaging flow cytometry technology. It would further help in research programs to develop novel imaging flow cytometry technology.

Growth in Demand for Cell Based Flow Cytometry

Among the technology segment, cell-based flow cytometry segment is expected to grow faster. Cell-based flow cytometry offers the advantage of high throughput and the potential to analyze millions of cells. Flow cytometry provides highly detailed information on single cells for immunotherapy clinical trials, enabling the monitoring of immune responses and the detection of abnormal cells. This technology monitors changes in immune cell phenotype, tracks therapeutic cells, and detects abnormal cells, thus offering a comprehensive view of a disease's micro-environment. In May 2023, Becton, Dickinson and Company, announced global commercial launch of an innovative cell sorting instrument, "BD FACSDiscover", a cell-based technology that will enable researchers to get more insights about cells in various areas, such as drug discovery, immuno-oncology and genomics, which is not possible in traditional flow cytometry experiments. BD FACSDiscover allows the investigation of different aspects of single-cell biology and sorts complex phenotypes for immunologic or genetic discovery.

North America Accounts for the Largest Share in Flow Cytometry Market

North America accounted for the largest share of the global flow cytometry market in 2022, with the United States being a major contributor to this dominance. The region's favorable business environment, substantial government support through funds and grants, and a robust healthcare infrastructure have driven its leadership in the flow cytometry market. Additionally, the high prevalence of HIV/AIDS and cancer has led to a growing focus on the development of treatment options for these target diseases, further propelling the demand for flow cytometry technologies.

The strong presence of key regional players, such as BD, Danaher Corporation, and Thermo Fisher Scientific, has also contributed to North America's market leadership. According to the CDC (Center for Disease Control), 6 out of 10 adults in the US are affected by a chronic disease, whereas 4 out of 10 adults in the USA have 2 or more chronic diseases. Thus, the significant prevalence of chronic and infectious diseases in this region will contribute to increased demand for rapid detection and diagnosis by flow cytometry.

Future Outlook of Global Flow Cytometry Market

Global flow cytometry market is expected to grow in the coming years, due to the growing elderly population and the increasing prevalence of infectious and chronic diseases globally. Technological advancements, research and development, government support, increasing healthcare budget, and collaborative ventures involving medical devices manufacturers, research institutions, and other healthcare providers are anticipated to drive the market growth over the forecasted period.

Key Players Landscape and Outlook

In the flow cytometry market, mergers and acquisitions, partnerships, and distribution agreements are pivotal in driving the global market. These alliances empower firms to adapt to each other's strengths, gain access to new markets and technologies, and pool resources for research and development. Distribution agreements enable companies to expand their market presence. These collaborative initiatives promote innovation, expedite product developments, and contribute to the development and growth of the global flow cytometry market. In February 2023, Luminex Corporation signed an agreement to sell all its flow cytometry & imaging (FCI) business unit assets to Cytek Biosciences. With this strategic acquisition, the company would gain insights into all facets of cellular phenotypes and morphology. There are more than 7,000 instruments, which will be under the Cytek umbrella following this acquisition that will further expand the company's global presence.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Flow Cytometry Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Products and Service
    • 4.2.1. Instruments
      • 4.2.1.1. Cell Analysers
      • 4.2.1.2. Cell Sorters
    • 4.2.2. Kits and Reagents
    • 4.2.3. Software and Services
    • 4.2.4. Others
  • 4.3. By Technology
    • 4.3.1. Cell-based Flow Cytometry
    • 4.3.2. Bead-based Flow Cytometry
  • 4.4. By Application
    • 4.4.1. Oncology
    • 4.4.2. Drug Discovery
    • 4.4.3. Stem Cell Therapy
    • 4.4.4. Hematology
    • 4.4.5. Immunology
    • 4.4.6. Other applications
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Clinical Testing Laboratories
    • 4.5.3. Academic & Research Institutes
    • 4.5.4. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. South America
    • 4.6.4. Asia-Pacific
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Flow Cytometry Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Product and Services
      • 5.1.2.1. Instruments
      • 5.1.2.1.1. Cell Analysers
      • 5.1.2.1.2. Cell Sorters
      • 5.1.2.2. Kits and Reagents
      • 5.1.2.3. Software and Services
      • 5.1.2.4. Others
    • 5.1.3. By Technology
      • 5.1.3.1. Cell-based Flow Cytometry
      • 5.1.3.2. Bead-based Flow Cytometry
    • 5.1.4. By Application
      • 5.1.4.1. Oncology
      • 5.1.4.2. Drug Discovery
      • 5.1.4.3. Stem Cell Therapy
      • 5.1.4.4. Hematology
      • 5.1.4.5. Immunology
      • 5.1.4.6. Other applications
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Clinical Testing Laboratories
      • 5.1.5.3. Academic & Research Institutes
      • 5.1.5.4. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. Value
      • 5.1.6.1.2. Volume
      • 5.1.6.2. By Product and Services
      • 5.1.6.2.1. Instruments
      • 5.1.6.2.1.1. Cell Analysers
      • 5.1.6.2.1.2. Cell Sorters
      • 5.1.6.2.2. Kits and Reagents
      • 5.1.6.2.3. Software and Services
      • 5.1.6.2.4. Others
      • 5.1.6.3. By Technology
      • 5.1.6.3.1. Cell-based Flow Cytometry
      • 5.1.6.3.2. Bead-based Flow Cytometry
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Oncology
      • 5.1.6.4.2. Drug Discovery
      • 5.1.6.4.3. Stem Cell Therapy
      • 5.1.6.4.4. Hematology
      • 5.1.6.4.5. Immunology
      • 5.1.6.4.6. Other applications
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Clinical Testing Laboratories
      • 5.1.6.5.3. Academic & Research Institutes
      • 5.1.6.5.4. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product and Services
  • 6.2. By Technology
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Becton, Dickinson and Company
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Thermo Fisher Scientific
  • 13.3. Bio-Rad Laboratories, Inc.
  • 13.4. Miltenyi Biotec B.V. & Co. KG
  • 13.5. Sysmex Asia Pacific Pte Ltd.
  • 13.6. Agilent Technologies, Inc.
  • 13.7. Sony Biotechnology Inc. LLC
  • 13.8. Enzo Life Sciences, Inc.
  • 13.9. Cytek Biosciences, Inc.
  • 13.10. Sartorius AG
  • 13.11. Apogee Flow Systems Ltd.
  • 13.12. Luminex Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 4. Global Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Flow Cytometry Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 11. North America Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 18. United States Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 24. Canada Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 30. Mexico Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 36. Europe Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 43. Germany Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 49. France Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 50. France Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 51. France Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 55. Italy Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 61. United Kingdom Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 67. Russia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 73. Netherlands Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 79. Spain Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 85. Turkey Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 91. Poland Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 97. South America Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 104. Brazil Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 110. Argentina Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 116. Asia-Pacific Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 120. India Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 123. India Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 124. India Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 125. India Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 129. China Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 130. China Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 131. China Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 135. Japan Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 141. Australia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 147. Vietnam Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 153. South Korea Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 159. Indonesia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 165. Philippines Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 171. Middle East & Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Flow Cytometry Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 178. Saudi Arabia Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 184. UAE Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
  • Figure 190. South Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023